SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-20-007431
Filing Date
2020-05-11
Accepted
2020-05-11 16:08:51
Documents
17
Period of Report
2020-05-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sgmo-20200511.htm   iXBRL 8-K 58240
2 EX-99.1 exhibit991.htm EX-99.1 62687
8 logo1.gif GRAPHIC 43773
9 table1.gif GRAPHIC 18907
  Complete submission text file 0001628280-20-007431.txt   361842

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sgmo-20200511.xsd EX-101.SCH 2603
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT sgmo-20200511_cal.xml EX-101.CAL 747
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT sgmo-20200511_def.xml EX-101.DEF 1693
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sgmo-20200511_lab.xml EX-101.LAB 24270
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sgmo-20200511_pre.xml EX-101.PRE 12683
12 EXTRACTED XBRL INSTANCE DOCUMENT sgmo-20200511_htm.xml XML 11082
Mailing Address 501 CANAL BLVD POINT RICHMOND TECH CNTR. RICHMOND CA 94804
Business Address 501 CANAL BLVD POINT RICHMOND TECH CNTR. RICHMOND CA 94804 5109706000
SANGAMO THERAPEUTICS, INC (Filer) CIK: 0001001233 (see all company filings)

IRS No.: 680359556 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30171 | Film No.: 20864832
SIC: 2836 Biological Products, (No Diagnostic Substances)